Event : Driving Quality and Compliance in Drug Development Through the FDA End-of-Phase 2A Meeting http://www.rsc.org/events/detail/10234/Driving%20Quality%20and%20Compliance%20in%20Drug%20Development%20Through%20the%20FDA%20End-of-Phase%202A%20Meeting This is a feed for event : Driving Quality and Compliance in Drug Development Through the FDA End-of-Phase 2A Meeting Thu, 11 Sep 2014 13:13:13 +0100 10234 10234 http://www.rsc.org/events/detail/10234/Driving%20Quality%20and%20Compliance%20in%20Drug%20Development%20Through%20the%20FDA%20End-of-Phase%202A%20Meeting Driving Quality and Compliance in Drug Development Through the FDA End-of-Phase 2A Meeting Event dates: 23 January 2014<br/>Event summary: This training on FDA compliance will provide the attendees with an understanding of FDA expectations regarding end-of-phase 2A meeting guidance. Attendees will learn the best practices to comply wit<br/>Event Venue: Online Event, Palo Alto, 94303, United States Thu, 11 Sep 2014 13:13:13 +0100 2014-09-11T13:13:13+01:00